Preclinical development of 1B7/CD3, a novel antiTSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL (vol 37, pg 2006, 2023)
LEUKEMIA(2024)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined